Older adults at higher risk for dementia benefited most from hearing aids in the ACHIEVE study. Among participants drawn from an existing heart and brain health study who had more cognitive risk factors at enrollment, a structured hearing intervention slowed cognitive decline over three years. The study did not find the same benefit across the full, more diverse group of participants. Consider two adults with similar untreated hearing loss.
One has diabetes, high blood pressure, and mildly reduced cognitive test scores; the other is generally healthy and begins with stronger cognitive performance. ACHIEVE suggests that treating hearing loss may make a measurable cognitive difference for the first person over several years, while any effect in the healthier person may be too small or slow to detect within the same period. The findings do not establish hearing aids as a treatment for dementia, nor do they prove that hearing loss directly causes cognitive decline. They do show that a well-supported hearing intervention may be especially valuable for older adults who already carry multiple dementia risk factors.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who Benefited From Hearing Aids in the ACHIEVE Study?
- Why the Overall ACHIEVE Result Requires Careful Interpretation
- How Hearing Loss Could Affect Cognitive Health
- What Older Adults and Families Can Do With the Findings
- Common Problems With Hearing Aids and Cognitive Claims
- Why Cardiovascular Risk Matters in the Higher-Risk Group
- Hearing Support for People Already Living With Cognitive Impairment
- Frequently Asked Questions
Who Benefited From Hearing Aids in the ACHIEVE Study?
ACHIEVE enrolled 977 adults ages 70 to 84 with untreated hearing loss and without substantial cognitive impairment. Participants were randomly assigned either to a hearing intervention or to a health education program focused on successful aging. The hearing intervention included professionally fitted hearing aids, counseling, assistive technology, and continuing support rather than simply handing participants a device. The clearest cognitive benefit appeared in participants recruited from the Atherosclerosis risk in Communities, or ARIC, study.
This group entered ACHIEVE with more risk factors for cognitive decline, including lower cognitive scores and higher rates of conditions such as diabetes and high blood pressure. In this higher-risk group, the hearing intervention was associated with a 48% reduction in the rate of global cognitive decline over three years compared with the health education program. Participants recruited separately from the community were generally healthier and began with better cognitive performance. Their cognitive scores changed relatively little in both study groups, leaving less room for hearing treatment to produce a detectable difference. This contrast matters: a null result in a healthier population does not necessarily mean that hearing care has no cognitive value, only that ACHIEVE did not demonstrate one for that group during the study period.
Why the Overall ACHIEVE Result Requires Careful Interpretation
When all participants were analyzed together, the hearing intervention did not significantly reduce three-year cognitive decline compared with the health education control. That was the study’s primary result, and it should not be replaced by the more encouraging subgroup finding. The evidence supports a possible benefit for higher-risk adults, not a universal claim that hearing aids prevent cognitive decline. The difference between the two recruitment groups was examined in a prespecified analysis, which makes it more informative than an unexpected subgroup discovered after the results were known.
Even so, subgroup findings require caution. The ARIC participants differed from the healthier volunteers in several ways, so the study cannot identify a single characteristic—such as diabetes, age, or baseline cognitive score—that determined who responded. The three-year follow-up is another limitation. Dementia-related changes often develop over much longer periods, while healthy participants may show little measurable decline in three years. A longer study might reveal a benefit, no benefit, or a different pattern among lower-risk adults; ACHIEVE alone cannot settle that question.
How Hearing Loss Could Affect Cognitive Health
Hearing loss may influence cognition through several overlapping pathways. Straining to understand speech can consume attention and working memory, leaving fewer mental resources for following a conversation or retaining information. Poor hearing may also contribute to social withdrawal, reduced stimulation, loneliness, and changes in brain structure or function. Shared causes—including vascular disease and aging—could affect both hearing and cognition. A practical example is a family dinner in a noisy restaurant.
An older adult who misses half the conversation may stop asking for repetition and gradually participate less. Properly fitted hearing aids will not eliminate every problem with background noise, but they may make sustained participation more manageable and reduce the tendency to disengage. Cognitive testing itself can also be affected by audibility. If a person mishears spoken instructions or test items, a low score may partly reflect communication difficulty rather than memory loss. Clinicians should ensure that hearing needs are addressed during an assessment, while recognizing that correcting audibility does not make a genuine neurocognitive disorder disappear.
What Older Adults and Families Can Do With the Findings
An older adult with hearing difficulty should begin with a hearing evaluation rather than treating ACHIEVE as a reason to buy a particular device. A clinician can assess the type and severity of hearing loss, examine the ears for treatable problems, and discuss hearing aids or other options. Sudden hearing loss, hearing loss in one ear, ear pain, drainage, or new dizziness warrants prompt medical attention. Device selection involves tradeoffs.
Over-the-counter hearing aids may be appropriate for some adults with perceived mild to moderate hearing loss and can cost less or be easier to obtain. Prescription hearing aids may offer more individualized fitting, verification, and follow-up, which can be especially useful for complex hearing loss, limited dexterity, cognitive impairment, or difficulty adjusting to amplification. Families can help by observing function rather than focusing only on whether the person admits to hearing loss. Repeatedly turning up the television, withdrawing in groups, answering questions incorrectly, or seeming confused during medical visits may signal an access problem. Scheduling follow-up adjustments and practicing in quieter settings can be more useful than expecting immediate success on the first day.
Common Problems With Hearing Aids and Cognitive Claims
Hearing aids frequently go unused because they feel uncomfortable, sound unnatural, amplify unwanted noise, or are difficult to maintain. Earwax, poor fit, dead batteries, clogged microphone ports, and incorrect settings can all make a suitable device seem ineffective. In ACHIEVE, participants received counseling and ongoing support, so its findings should not be assumed to apply equally to devices purchased and left unadjusted in a drawer. Adaptation also takes time. A person who has lived with hearing loss for years may find ordinary sounds surprisingly sharp or distracting after amplification.
Gradual wear, professional adjustment, and realistic communication strategies—such as facing the speaker and reducing background noise—may improve adherence. Severe difficulty understanding speech may persist even when sounds become louder. Families should be wary of claims that hearing aids can prevent, reverse, or cure dementia. ACHIEVE measured changes in cognitive test performance over three years; it did not establish hearing aids as a dementia therapy. Memory problems, disorientation, changes in judgment, or loss of daily skills still require a medical evaluation even when untreated hearing loss is present.
Why Cardiovascular Risk Matters in the Higher-Risk Group
The stronger result among ARIC participants fits with broader evidence that brain health, vascular health, and sensory function are interconnected. Conditions such as diabetes and high blood pressure can damage small blood vessels and may contribute to both auditory and cognitive problems.
Hearing care therefore belongs alongside—not in place of—blood pressure management, physical activity, diabetes care, sleep evaluation, and social engagement. For example, an adult with hearing loss and poorly controlled hypertension should not choose between hearing aids and cardiovascular care. Addressing communication barriers may help that person understand medication instructions and remain socially active, while treating hypertension targets a different pathway associated with cognitive risk.
Hearing Support for People Already Living With Cognitive Impairment
People with mild cognitive impairment or dementia may need simplified hearing routines. Useful measures include rechargeable devices, labeled storage, a written morning checklist, caregiver help with cleaning, and a consistent location for charging. A pocket-style amplifier may sometimes help during a medical appointment if hearing aids are unavailable or temporarily not working.
Communication adjustments remain necessary even with well-fitted devices. A caregiver can gain the person’s attention, speak face-to-face in a quiet room, use short sentences, and allow extra response time. If someone becomes unusually confused during a conversation, checking whether the hearing aids are inserted, charged, clean, and functioning is a concrete first step before assuming that cognition has suddenly worsened.
Frequently Asked Questions
Did the ACHIEVE study prove that hearing aids prevent dementia?
No. The overall trial did not show a significant reduction in cognitive decline, and the study did not establish that hearing aids prevent or treat dementia. It found a meaningful slowing of decline in a prespecified group with higher baseline risk.
How much did cognitive decline slow in the higher-risk group?
Among participants recruited from the ARIC study, the hearing intervention was associated with a 48% reduction in the rate of global cognitive decline over three years compared with health education.
Did healthier participants benefit cognitively?
ACHIEVE did not detect a cognitive benefit in the healthier community-recruited group during three years of follow-up. Both intervention groups in that cohort experienced relatively little decline.
Was the intervention limited to receiving hearing aids?
No. It included hearing aids fitted by audiologists, counseling, assistive technology, and ongoing support. That distinction limits comparisons with unsupported or inconsistently used devices.
Should a person with memory concerns get hearing tested?
Yes, especially if conversations, television, telephone calls, or medical visits have become difficult. Hearing assessment can identify a treatable communication barrier, but it should accompany rather than replace evaluation of persistent cognitive symptoms.
